IL144756A0 - Method for controlling liposome size - Google Patents
Method for controlling liposome sizeInfo
- Publication number
- IL144756A0 IL144756A0 IL14475600A IL14475600A IL144756A0 IL 144756 A0 IL144756 A0 IL 144756A0 IL 14475600 A IL14475600 A IL 14475600A IL 14475600 A IL14475600 A IL 14475600A IL 144756 A0 IL144756 A0 IL 144756A0
- Authority
- IL
- Israel
- Prior art keywords
- solvent
- lipid
- liposome size
- particle size
- lipid solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11922999P | 1999-02-08 | 1999-02-08 | |
PCT/US2000/003039 WO2000045791A2 (en) | 1999-02-08 | 2000-02-03 | Method for controlling liposome size |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144756A0 true IL144756A0 (en) | 2002-06-30 |
Family
ID=22383233
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14475600A IL144756A0 (en) | 1999-02-08 | 2000-02-03 | Method for controlling liposome size |
IL144756A IL144756A (en) | 1999-02-08 | 2001-08-06 | A method for controlling the size of the liposome |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL144756A IL144756A (en) | 1999-02-08 | 2001-08-06 | A method for controlling the size of the liposome |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1150658B1 (es) |
JP (1) | JP2002536316A (es) |
KR (1) | KR20010101837A (es) |
CN (1) | CN1198589C (es) |
AT (1) | ATE272392T1 (es) |
AU (1) | AU773515B2 (es) |
CA (1) | CA2361551A1 (es) |
DE (1) | DE60012693T2 (es) |
ES (1) | ES2225094T3 (es) |
HK (1) | HK1040642A1 (es) |
HU (1) | HUP0200421A3 (es) |
IL (2) | IL144756A0 (es) |
NO (1) | NO20013862L (es) |
WO (1) | WO2000045791A2 (es) |
ZA (1) | ZA200106444B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
AU2003287526A1 (en) * | 2002-11-06 | 2004-06-03 | Protein-stabilized liposomal formulations of pharmaceutical agents | |
EP1617808A4 (en) | 2003-04-25 | 2011-11-02 | Penn State Res Found | METHOD AND SYSTEM FOR THE SYSTEMIC DISTRIBUTION OF GROWTH-INHIBITORS OF LIPID-DERIVED BIOACTIVE COMPOUNDS |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
KR100684380B1 (ko) * | 2005-05-24 | 2007-02-20 | 한국화학연구원 | 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법 |
CA2838111C (en) | 2005-12-08 | 2016-01-19 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
JP5600432B2 (ja) * | 2006-04-06 | 2014-10-01 | インスメッド, インコーポレイテッド | コアセルベート化誘導リポソーム被包法及びその調合物 |
US20100196455A1 (en) | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
WO2010010985A1 (en) * | 2008-07-24 | 2010-01-28 | Amorepacific Corporation | Multi-layered lamellar granule and skin external application composition containing same |
EA201170286A1 (ru) * | 2008-12-24 | 2011-10-31 | Байомедкор Инк. | Способ получения липосом и способ растворения холестерина |
JP5771366B2 (ja) * | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
WO2011162093A1 (ja) * | 2010-06-23 | 2011-12-29 | 学校法人神奈川大学 | 乳化物製造用親水性ナノ粒子の製造方法 |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
US9820940B2 (en) * | 2012-08-17 | 2017-11-21 | University Of Houston System | Liposomal formulations of polymyxin and uses thereof |
JP6332902B2 (ja) * | 2012-10-29 | 2018-05-30 | 株式会社ピカソ美化学研究所 | 美容用組成物 |
EP3581186A1 (en) | 2012-11-29 | 2019-12-18 | Insmed Incorporated | Stabilized vancomycin formulations |
SG11201601311VA (en) * | 2013-09-13 | 2016-03-30 | Arbor Therapeutics Llc | Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
WO2019088193A1 (ja) * | 2017-11-01 | 2019-05-09 | 国立大学法人大阪大学 | 所望の粒径を有する脂質粒子を製造するための方法および装置の開発 |
EP3773505A4 (en) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS |
CN114588125B (zh) * | 2022-02-25 | 2023-02-28 | 北京科技大学 | 靶向载药溶栓微泡及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61189215A (ja) * | 1985-02-18 | 1986-08-22 | Teijin Ltd | 5−フルオロ−2′−デオキシウリジンエステル類の油状医薬組成物 |
DE4013580A1 (de) * | 1990-04-24 | 1991-10-31 | Schering Ag | Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen |
RU2085192C1 (ru) * | 1993-02-03 | 1997-07-27 | Экспериментальное предприятие медико-биологических препаратов Кардиологического научного центра РАМН | Способ получения липосомальной формы альфа-токоферола и гомогенизирующий клапан для его осуществления |
ES2154680T3 (es) * | 1993-07-08 | 2001-04-16 | Liposome Co Inc | Metodo para controlar el tamaño de los liposomas. |
US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
TWI225412B (en) * | 1997-06-23 | 2004-12-21 | Sequus Pharm Inc | Liposome-entrapped polynucleotide composition and method |
-
2000
- 2000-02-03 ES ES00907183T patent/ES2225094T3/es not_active Expired - Lifetime
- 2000-02-03 HU HU0200421A patent/HUP0200421A3/hu unknown
- 2000-02-03 CA CA002361551A patent/CA2361551A1/en not_active Abandoned
- 2000-02-03 JP JP2000596911A patent/JP2002536316A/ja active Pending
- 2000-02-03 EP EP00907183A patent/EP1150658B1/en not_active Expired - Lifetime
- 2000-02-03 CN CNB008035075A patent/CN1198589C/zh not_active Expired - Fee Related
- 2000-02-03 AT AT00907183T patent/ATE272392T1/de not_active IP Right Cessation
- 2000-02-03 WO PCT/US2000/003039 patent/WO2000045791A2/en not_active Application Discontinuation
- 2000-02-03 IL IL14475600A patent/IL144756A0/xx active IP Right Grant
- 2000-02-03 KR KR1020017010024A patent/KR20010101837A/ko not_active Application Discontinuation
- 2000-02-03 DE DE2000612693 patent/DE60012693T2/de not_active Expired - Fee Related
- 2000-02-03 AU AU28718/00A patent/AU773515B2/en not_active Ceased
-
2001
- 2001-08-06 ZA ZA200106444A patent/ZA200106444B/xx unknown
- 2001-08-06 IL IL144756A patent/IL144756A/en not_active IP Right Cessation
- 2001-08-08 NO NO20013862A patent/NO20013862L/no not_active Application Discontinuation
-
2002
- 2002-04-04 HK HK02102545A patent/HK1040642A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP0200421A2 (en) | 2002-06-29 |
IL144756A (en) | 2007-06-03 |
HK1040642A1 (en) | 2002-06-21 |
ATE272392T1 (de) | 2004-08-15 |
AU773515B2 (en) | 2004-05-27 |
EP1150658A2 (en) | 2001-11-07 |
ZA200106444B (en) | 2002-08-06 |
EP1150658B1 (en) | 2004-08-04 |
KR20010101837A (ko) | 2001-11-14 |
ES2225094T3 (es) | 2005-03-16 |
WO2000045791A3 (en) | 2000-12-21 |
CN1338923A (zh) | 2002-03-06 |
HUP0200421A3 (en) | 2005-04-28 |
DE60012693T2 (de) | 2005-01-13 |
WO2000045791A2 (en) | 2000-08-10 |
CN1198589C (zh) | 2005-04-27 |
JP2002536316A (ja) | 2002-10-29 |
DE60012693D1 (de) | 2004-09-09 |
NO20013862D0 (no) | 2001-08-08 |
NO20013862L (no) | 2001-10-08 |
AU2871800A (en) | 2000-08-25 |
CA2361551A1 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144756A0 (en) | Method for controlling liposome size | |
DE69938875D1 (es) | ||
IE801201L (en) | Cementitious product. | |
CA2355269A1 (en) | Materials and methods for making improved micelle compositions | |
CA2386577A1 (en) | System and method for making wallboard or backerboard sheets including aerated concrete | |
DK0843547T3 (da) | Fremgangsmåder til at fremstille liposomer, der indeholder hydromonobenzoporphyrin- fotosensibilisatorer | |
AU3922193A (en) | Liposome encapsulated taxol and a method of using the same | |
ES8607906A1 (es) | Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares | |
AU2127697A (en) | Method of preparing polynucleotide-carrier complexes for delivery to cells | |
AU588101B2 (en) | Machine for unrolling, assembling and laying rolls of pre-cultivated turf | |
AU6036596A (en) | Process for making liposome preparation | |
MY123986A (en) | Method and composition for producing set gypsum-containing product with increased strenght, rigidity, and dimensional stability | |
WO1998019709A3 (en) | Cationic reagents for transfection | |
MY115679A (en) | Process for preparing intermediates to florfenicol | |
DE3070993D1 (en) | Polymerisable phospholipids and polymers thereof, methods for their preparation, methods for their use in coating substrates and forming liposomes and the resulting coated substrates and liposome compositions | |
IN190388B (es) | ||
NZ503293A (en) | Liposomal camptothecin formulations also comprising at least one phospholipid | |
ZA200205468B (en) | Liposomes containing an entrapped compound in supersaturated solution. | |
AU1791297A (en) | Phosphatidyl oligoglycerols | |
AU9532198A (en) | Ribonucleoside-derivative and method for preparing the same | |
CA2326348A1 (en) | Liposomal bupivacaine compositions and methods of preparation | |
IE900285L (en) | Peptides with sulphate ester groups. | |
EP0956337A4 (en) | COMPOSITIONS AND METHODS RELATING TO THE PRODUCTION, ISOLATION AND MODIFICATION OF GAS MICROBUBBLES | |
EP0800822A3 (en) | Method for preparing closed vesicles by rehydration of dehydrated vesicles | |
CA2229892A1 (en) | Liposome preparations of indolocarbazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |